TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT07457632

Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine.

Cause of deathRegulatory or ethics Automatic label, confidence 0.9, unverified. How labels are made.
“The study was terminated due to additional regulatory requirements that could not be completed within the established academic timeline. As a result, continuation of the study was not feasible.”

The sponsor’s own words in the registry.

Life of this trial

202620272028Registered2026-03-03Planned start2026-10-01 (planned)Withdrawn (as of)2026-10-09

Vital statistics

Status
Withdrawn
Phase
Phase 2
Sponsor
University of Alabama at Birmingham
Sponsor type
University, hospital or other
Conditions
Diabetic Macular Edema (DME)
Interventions
Tauroursodeoxycholate (TUDCA); Traditional Chinese Medicine (mQJDHW); placebo capsule
Participants
0

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.